AIDS and Behavior

, Volume 18, Issue 7, pp 1302–1314

Problematic Alcohol Use Among Individuals with HIV: Relations with Everyday Memory Functioning and HIV Symptom Severity

  • Adrienne J. Heinz
  • Kethera A. Fogler
  • Michael E. Newcomb
  • Jodie A. Trafton
  • Marcel O. Bonn-Miller
Original Paper

Abstract

Problematic alcohol use has been shown to negatively impact cognitive functions germane to achieving optimal HIV health outcomes. The present study, a secondary data analysis, examined the impact of problematic alcohol use on aspects of everyday memory functioning in a sample of 172 HIV-infected individuals (22 % female; Mage = 48.37 years, SD = 8.64; 39 % Black/non-Hispanic). Additionally, we tested whether self-reported memory functioning explained the relation between problematic alcohol use and HIV symptom severity. Results indicated that problematic patterns of alcohol use were associated with lower total memory functioning, retrieval (e.g., recall-difficulty) and memory for activity (e.g., what you did yesterday) and greater HIV symptom severity. Memory functioning mediated the relation between problematic alcohol use and HIV symptom severity. However, the direction of this relation was unclear as HIV symptom severity also mediated the relation between problematic alcohol use and memory functioning. Findings highlight the importance of integrated care for HIV and alcohol use disorders and suggest that routine alcohol and cognitive screenings may bolster health outcomes among this vulnerable population.

Keywords

Alcohol Drinking Cognitive Memory HIV Symptoms 

References

  1. 1.
    Conigliaro J, Justice AC, Gordon AJ, Bryant K. Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: a conceptual model to guide the implementation of evidence-based interventions into practice. Med Care. 2006;44:S1–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16:83–8.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Justice AC, Lasky E, McGinnis KA, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care. 2006;44:S52–60.PubMedCrossRefGoogle Scholar
  4. 4.
    Lefevre F, O’Leary B, Moran M, et al. Alcohol consumption among HIV-infected patients. J Gen Intern Med. 1995;10:458–60.PubMedCrossRefGoogle Scholar
  5. 5.
    Miguez MJ, Shor-Posner G, Morales G, Rodriguez A, Burbano X. HIV treatment in drug abusers: impact of alcohol use. Addict Biol. 2003;8:33–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W. Comorbidity and survival in HIV-infected men in the San Francisco men’s health survey. Ann Epidemiol. 1996;6:420–30.PubMedCrossRefGoogle Scholar
  7. 7.
    Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28:572–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–80.PubMedCrossRefGoogle Scholar
  9. 9.
    Galvan FH, Burnam MA, Bing EG. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoact Drugs. 2003;35:153–60.CrossRefGoogle Scholar
  10. 10.
    Petry NM. Alcohol use in HIV patients: what we don’t know may hurt us. Int J STD AIDS. 1999;10:561–70.PubMedCrossRefGoogle Scholar
  11. 11.
    Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112:178–93.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res. 2005;29:1190–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52:180–202.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Kresina TF, Flexner CW, Sinclair J, et al. Alcohol use and HIV pharmacotherapy. AIDS Res Hum Retrovir. 2002;18:757–70.PubMedCrossRefGoogle Scholar
  15. 15.
    Palepu A, Horton N, Tibbetts N, Meli S, Samet J. Adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004;99:361–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Rothlind JC, Greenfield TM, Bruce AV, et al. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc. 2005;11:70–83.PubMedCentralPubMedGoogle Scholar
  17. 17.
    Wang X, Douglas SD, Metzger DS, et al. Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes. Alcohol Clin Exp Res. 2002;26:1880–6.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Wang Y, Watson RR. Is alcohol consumption a cofactor in the development of acquired immunodeficiency syndrome? Alcohol. 1995;12:105–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Samet JH, Horton NJ, Traphagen ET, Lyon SM, Freedberg KA. Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res. 2003;27:862–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Braithwaite RS, Conigliaro J, Roberts MS, et al. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19:459–66.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Rosenbloom MJ, Sullivan EV, Sassoon SA, et al. Alcoholism, HIV infection, and their comorbidity: factors affecting self-rated health-related quality of life. J Stud Alcohol Drugs. 2007;68:115–25.PubMedGoogle Scholar
  22. 22.
    Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med. 1998;104:129–36.PubMedCrossRefGoogle Scholar
  23. 23.
    Gakhar H, Kamali A, Holodniy M. Health-related quality of life assessment after antiretroviral therapy: a review of the literature. Drugs. 2013;73:1–22.CrossRefGoogle Scholar
  24. 24.
    Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I. Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol. 2006;28:536–48.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Maki PM, Cohen MH, Weber K, et al. Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study. Neurology. 2009;72:1661–8.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Martin EM, Nixon H, Pitrak DL, et al. Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: preliminary observations. J Clin Exp Neuropsychol. 2007;29:496–504.PubMedCrossRefGoogle Scholar
  27. 27.
    Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS. 2011;25:561–75.PubMedCrossRefGoogle Scholar
  28. 28.
    Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19:152–68.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19:169–85.PubMedCrossRefGoogle Scholar
  30. 30.
    Foley J, Ettenhofer M, Wright M, Hinkin CH. Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep. 2008;5:204–11.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ. Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol. 2010;16:101–14.PubMedCrossRefGoogle Scholar
  32. 32.
    Hinkin CH, Castellon S, Durvasula R, et al. Medication adherence among HIV+ adults—Effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944–50.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19–25.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Lovejoy TI, Suhr JA. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med. 2009;32:389–405.PubMedCrossRefGoogle Scholar
  35. 35.
    Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14:1213–26.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Green A, Garrick T, Sheedy D, Blake H, Shores E, Harper C. The effect of moderate to heavy alcohol consumption on neuropsychological performance as measured by the repeatable battery for the assessment of neuropsychological status. Alcohol Clin Exp Res. 2010;34:443–50.PubMedCrossRefGoogle Scholar
  37. 37.
    Parsons OA. Neurocognitive deficits in alcoholics and social drinkers. Alcohol Clin Exp Res. 1998;22:954–61.PubMedGoogle Scholar
  38. 38.
    Brandt J, Butters N, Ryan C, Bayog R. Cognitive loss and recovery in long-term alcohol abusers. Arch Gen Psychiatry. 1983;40:435–42.PubMedCrossRefGoogle Scholar
  39. 39.
    Máttyássy A, Kéri S, Myers CE, Levy-Gigi E, Gluck MA, Kelemen O. Impaired generalization of associative learning in patients with alcohol dependence after intermediate-term abstinence. Alcohol Alcohol. 2012;47:533–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Wilkinson D, Poulos C. The chronic effects of alcohol on memory: a contrast between a unitary and dual system approach. Recent Dev in Alcohol. 1987;5:5–25.CrossRefGoogle Scholar
  41. 41.
    Parsons OA, Nixon SJ. Cognitive functioning in sober social drinkers: a review of the research since 1986. J Stud Alcohol. 1998;59:180–90.PubMedGoogle Scholar
  42. 42.
    Selnes OA. Impact of HIV infection and alcohol on cognition: a review. Neurobehav HIV Med. 2010;2:85–94.CrossRefGoogle Scholar
  43. 43.
    Fama R, Rosenbloom MJ, Sassoon SA, Pfefferbaum A, Sullivan EV. Differential effect of alcoholism and HIV infection on visuomotor procedural learning and retention. Alcohol Clin Exp Res. 2012;36:1738–47.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Fama R, Rosenbloom MJ, Nichols BN, Pfefferbaum A, Sullivan EV. Working and episodic memory in HIV infection, alcoholism, and their comorbidity: baseline and 1-year follow-up examinations. Alcohol Clin Exp Res. 2009;33:1815–24.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Durvasula RS, Myers HF, Mason K, Hinkin C. Relationship between alcohol use/abuse, HIV infection and neuropsychological performance in African American men. J Clin Exp Neuropsychol. 2006;28:383–404.PubMedCentralPubMedCrossRefGoogle Scholar
  46. 46.
    Green JE, Saveanu RV, Bornstein RA. The effect of previous alcohol abuse on cognitive function in HIV infection. Am J Psychiatry. 2004;161:249–54.PubMedCrossRefGoogle Scholar
  47. 47.
    Sbordon RJ, Long CJ. Ecological validity of neuropsychological testing. Boca Raton: CRC Press; 1996.Google Scholar
  48. 48.
    Chaytor N, Schmitter-Edgecombe M, Burr R. Improving the ecological validity of excutive functioning assessment. Archives of Clin Neuropsychol. 2005;21:217–27.CrossRefGoogle Scholar
  49. 49.
    Burgess PW, Alderman N, Evans J, Emslie H, Wilson BA. The ecological validity of tests of executive function. J of Int Neuropsychol Soc. 1998;4:547–58.Google Scholar
  50. 50.
    de Groot JC, De Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MMB. Cerebral white matter lesions and subjective cognitive dysfunction the rotterdam scan study. Neurology. 2001;46:1539–45.CrossRefGoogle Scholar
  51. 51.
    Schmand B, Jonker C, Hooijer C, Lindeboom J. Subjective memory complaints may announce dementia. Neurology. 1996;46:121–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Carter SL, Rourke SB, Murji S, Shore D, Rourke BP. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology. 2003;17:410–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317–31.PubMedGoogle Scholar
  54. 54.
    Zogg JB, Woods SP, Sauceda JA, Wiebe JS, Simoni JM. The role of prospective memory in medication adherence: a review of an emerging literature. J Behav Med. 2012;35:47–62.PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Woods SP, Moran LM, Carey CL, et al. Prospective memory in HIV infection: is “remembering to remember” a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23:257–70.PubMedCentralPubMedCrossRefGoogle Scholar
  56. 56.
    Lenderking WR, Testa MA, Katzenstein D, Hammer S. Measuring quality of life in early HIV disease: the modular approach. Qual Life Res. 1997;6:515–30.PubMedCrossRefGoogle Scholar
  57. 57.
    Kraemer KL, McGinnis KA, Skanderson M, et al. Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care. 2006;44:S44–51.PubMedCrossRefGoogle Scholar
  58. 58.
    Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2012;1-10.Google Scholar
  59. 59.
    Cornish IM. Factor structure of the everyday memory questionnaire. B J Psychol. 2000;91:427–38.CrossRefGoogle Scholar
  60. 60.
    Sunderland A, Harris JE, Baddeley AD. Do laboratory tests predict everyday memory? A neuropsychological study. J Verbal Learning Verbal Behav. 1983;22:341–57.CrossRefGoogle Scholar
  61. 61.
    Efklides A, Yiultsi E, Kangellidou T, Kounti F, Dina F, Tsolaki M. Wechsler memory scale, rivermead behavioral memory test, and everyday memory questionnaire in healthy adults and alzheimer patients. Eur J Psychol Assess. 2002;18:63–77.CrossRefGoogle Scholar
  62. 62.
    Olsson E, Wik K, Ostling A-K, Johansson M, Andersson G. Everyday memory self-assessed by adult patients with acquired brain damage and their significant others. Neuropsychol Rehab. 2006;16:257–71.CrossRefGoogle Scholar
  63. 63.
    Schwartz AF, Mcmillan TM. Assessment of everyday memory after severe head-injury. Cortex. 1989;25:665–71.PubMedCrossRefGoogle Scholar
  64. 64.
    Fisk JE, Montgomery C. Real-world memory and executive processes in cannabis users and non-users. J Psychopharmacol. 2008;22:727–36.PubMedCrossRefGoogle Scholar
  65. 65.
    Hadjiefthyvoulou F, Fisk JE, Montgomery C, Bridges N. Everyday and prospective memory deficits in ecstasy/polydrug users. J Psychopharmacol. 2011;25:453–64.PubMedCrossRefGoogle Scholar
  66. 66.
    Ling J, Heffernan TM, Buchanan T, Rodgers J, Scholey AB, Parrott AC. Effects of alcohol on subjective ratings of prospective and everyday memory deficits. Alcohol Clin Exp Res. 2003;27:970–4.PubMedCrossRefGoogle Scholar
  67. 67.
    Saunders JB, Aasland OG, Babor TF, Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 1993;88:791–804.PubMedCrossRefGoogle Scholar
  68. 68.
    First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV (SCID-I) (user’s guide and interview) research version 1995; New York, NY.Google Scholar
  69. 69.
    Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255–66.PubMedCrossRefGoogle Scholar
  70. 70.
    Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28:445–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–45.PubMedCrossRefGoogle Scholar
  72. 72.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 2000.Google Scholar
  73. 73.
    Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161:1967–77.PubMedCrossRefGoogle Scholar
  74. 74.
    Bonn-Miller MO, Zvolensky MJ. An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addict. 2009;18:409–16.PubMedCrossRefGoogle Scholar
  75. 75.
    Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Brit J Addiction. 1991;86:1119–27.CrossRefGoogle Scholar
  76. 76.
    Vidrine DJ. Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Educ Prev. 2009;21:3–13.PubMedCrossRefGoogle Scholar
  77. 77.
    Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients. Drugs. 2006;66:769–89.PubMedCrossRefGoogle Scholar
  78. 78.
    Woods SP, Carey CL, Moran LM, Dawson MS, Letendre SL, Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Arch Clin Neuropsychol. 2007;22:187–95.PubMedCentralPubMedCrossRefGoogle Scholar
  79. 79.
    Hartzell JD, Janke IE, Weintrob AC. Impact of depression on HIV outcomes in the HAART era. J Antimicrob Chemother. 2008;62:246–55.PubMedCrossRefGoogle Scholar
  80. 80.
    Kilbourne AM, Justice AC, Rollman BL, et al. Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med. 2002;17:512–20.PubMedCentralPubMedCrossRefGoogle Scholar
  81. 81.
    Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–82.PubMedCrossRefGoogle Scholar
  82. 82.
    Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods. 2004;36:717–31.CrossRefGoogle Scholar
  83. 83.
    Sobel ME. Asymptotic intervals for indirect effects in structural equations models. Sociol Methodol. 1982;13:290–312.CrossRefGoogle Scholar
  84. 84.
    Sheets VL, Braver SL. Organizational status and perceived sexual harassment: detecting the mediators of a null effect. Pers Soc Psychol Bull. 1999;25:1159–71.CrossRefGoogle Scholar
  85. 85.
    Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002;7(4):422–55.PubMedCrossRefGoogle Scholar
  86. 86.
    Copenhaver M, Avants SK, Warburton LA, Margolin A. Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment. J Psychoact Drugs. 2003;35:209–18.CrossRefGoogle Scholar
  87. 87.
    Rupp CI, Kemmler G, Kurz M, Hinterhuber H, Fleischhacker WW. Cognitive remediation therapy during treatment for alcohol dependence. J Stud Alcohol Drugs. 2012;73(4):625–34.PubMedGoogle Scholar
  88. 88.
    Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacol Rev. 2012;37:43–76.CrossRefGoogle Scholar
  89. 89.
    Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retrovir. 2004;20:151–5.PubMedCrossRefGoogle Scholar
  90. 90.
    Weber E, Morgan EE, Iudicello JE, et al. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol. 2013;19(1):65–74.PubMedCentralPubMedCrossRefGoogle Scholar
  91. 91.
    Basso MR, Bornstein RA. Neurobehavioural consequences of substance abuse and HIV infection. J Psychopharmacol. 2000;14:228–37.PubMedCrossRefGoogle Scholar
  92. 92.
    Fitting S, Ignatowska-Jankowska BM, Bull C, et al. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus Type-1 Tat transgenic mice. Biol Psychiatry. 2012;73(5):443–53.PubMedCentralPubMedCrossRefGoogle Scholar
  93. 93.
    Sarkar S, Chang SL. Ethanol concentration-dependent alterations in gene expression during acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res. 2013;37(7):1082–90.PubMedCentralPubMedCrossRefGoogle Scholar
  94. 94.
    Maxwell SE, Cole DA. Bias in cross-sectional analyses of longitudinal mediation. Psychol Methods. 2007;12:23–44.PubMedCrossRefGoogle Scholar
  95. 95.
    Hinkin CH, van Gorp WG, Satz P, et al. Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol. 1996;18:431–43.PubMedCrossRefGoogle Scholar
  96. 96.
    Blackstone K, Moore DJ, Franklin DR, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012;26:894–908.PubMedCrossRefGoogle Scholar
  97. 97.
    Zogg JB, Woods SP, Weber E, Iudicello JE, Dawson MS, Grant I. HIV-associated prospective memory impairment in the laboratory predicts failures on a semi-naturalistic measure of health care compliance. Clin Neuropsychol. 2010;24:945–62.PubMedCentralPubMedCrossRefGoogle Scholar
  98. 98.
    Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22:110–7.PubMedCentralPubMedCrossRefGoogle Scholar
  99. 99.
    Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80:404–15.PubMedCentralPubMedCrossRefGoogle Scholar
  100. 100.
    Ezeabogu I, Copenhaver MM, Potrepka J. AIDS care: psychological and socio-medical aspects of AIDS/HIV the influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care. 2012;24:386–93.PubMedCentralPubMedCrossRefGoogle Scholar
  101. 101.
    Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376:367–87.PubMedCrossRefGoogle Scholar
  102. 102.
    Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007;18:306–12.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Adrienne J. Heinz
    • 1
    • 2
  • Kethera A. Fogler
    • 3
  • Michael E. Newcomb
    • 4
  • Jodie A. Trafton
    • 1
    • 2
  • Marcel O. Bonn-Miller
    • 1
    • 5
    • 6
  1. 1.Center for Health Care EvaluationVA Palo Alto Health Care SystemMenlo ParkUSA
  2. 2.Department of Psychiatry and Behavioral SciencesStanford University School of MedicinePalo AltoUSA
  3. 3.Department of PsychologyJames Madison UniversityHarrisonburgUSA
  4. 4.Northwestern University Feinberg School of MedicineChicagoUSA
  5. 5.Center of Excellence in Substance Abuse Treatment and EducationPhiladelphia VAMCPhiladelphiaUSA
  6. 6.National Center for PTSDVA Palo Alto Health Care SystemMenlo ParkUSA

Personalised recommendations